Fractalkine/CX3CL1 engages different neuroprotective responses upon selective glutamate receptor overactivation

Frontiers in Cellular Neuroscience

Volumn 8, Issue JAN, 2015, Pages

  Lauro, Clotilde ^a   Catalano, Myriam ^a,b   Di Paolo, Eleonora ^c   Chece, Giuseppina ^a   de Costanzo, Ida ^a   Trettel, Flavia ^a   Limatola, Cristina ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

A2A< inf>R; CX3CL1; D serine; Excitotoxicity; Neuroprotection; NMDA

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FRACTALKINE; GLUTAMATE RECEPTOR; LACTATE DEHYDROGENASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DEATH; CELL VIABILITY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; EXCITOTOXICITY; HIPPOCAMPAL NEURONAL CULTURE; MOUSE; MTT ASSAY; NEUROPROTECTION; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING;

EID: 84937558922     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00472     Document Type: Article

References (59)

1. Blondeau, N., Widmann, C., Lazdunski, M., and Heurteaux, C. (2001). Activation of the nuclear factor-kappaB is a key event in brain tolerance. J. Neurosci. 21, 4668-4677.
2. Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P., and Lipton, S. A. (1995). Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. U S A 92, 7162-7166. doi: 10. 1073/pnas. 92. 16. 7162.
3. Chen, J. F., Huang, Z., Ma, J., Zhu, J., Moratalla, R., Standaert, D., et al. (1999). A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19, 9192-9200.
4. Chen, M., Lu, T. J., Chen, X. J., Zhou, Y., Chen, Q., Feng, X. Y., et al. (2008). Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance. Stroke 39, 3042-3048. doi: 10. 1161/strokeaha. 108. 521898.
5. Choi, D. W. (1987). Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7, 369-379.
6. Choi, D. W., Koh, J. Y., and Peters, S. (1988). Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J. Neurosci. 8, 185-196.
7. Deiva, K., Geeraerts, T., Salim, H., Leclerc, P., Héry, C., Hugel, B., et al. (2004). Fractalkine reduces N-methyl-d-aspartate-induced calcium flux and apoptosis in human neurons through extracellular signal-regulated kinase activation. Eur. J. Neurosci. 20, 3222-3232. doi: 10. 1111/j. 1460-9568. 2004. 03800. x.
8. Ghasemi, M., Phillips, C., Trillo, L., De Miguel, Z., Das, D., and Salehi, A. (2014). The role of NMDA receptors in the pathophysiology and treatment of mood disorders. Neurosci. Biobehav. Rev. 16, 336-358. doi: 10. 1016/j. neubiorev. 2014. 08. 017.
9. Grabb, M. C., and Choi, D. W. (1999). Ischemic tolerance in murine cortical cell culture: critical role for MDA receptors. J. Neurosci. 19, 1657-1662.
10. Hardingham, G. E. (2006). Pro-survival signalling from the NMDA receptor. Biochem. Soc. Trans. 34, 936-938. doi: 10. 1042/bst0340936.
11. Hardingham, G. E., Arnold, F. J., and Bading, H. (2001a). A calcium microdomain near NMDA receptors: on switch for ERK-dependent synapse-to-nucleus communication. Nat. Neurosci. 4, 565-566. doi: 10. 1038/88380.
12. Hardingham, G. E., Arnold, F. J., and Bading, H. (2001b). Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity. Nat. Neurosci. 4, 261-267. doi: 10. 1038/85109.
13. Hardingham, G. E., and Bading, H. (2010). Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat. Rev. Neurosci. 11, 682-696. doi: 10. 1038/nrn2911.
14. Hardingham, G. E., Fukunaga, Y., and Bading, H. (2002). Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci. 5, 405-414. doi: 10. 1038/nn835.
15. Hetman, M., and Kharebava, G. (2006). Survival signaling pathways activated by NMDA receptors. Curr. Top. Med. Chem. 6, 787-799. doi: 10. 2174/156802606777057553.
16. Hetman, M., and Xia, Z. (2000). Signaling pathways mediating anti-apoptotic action of neurotrophins. Acta Neurobiol. Exp. 60, 531-545.
17. Ikeda, K., Nagasawa, M., Mori, H., Araki, K., Sakimura, K., Watanabe, M., et al. (1992). Cloning and expression of the epsilon 4 subunit of the NMDA receptor channel. FEBS Lett. 313, 34-38. doi: 10. 1016/0014-5793(92)81178-o.
18. Ikonomidou, C., and Turski, L. (2002). Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 1, 383-386. doi: 10. 1016/s1474-4422(02)00164-3.
19. Jacobson, K. A., and Gao, Z. G. (2006). Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 5, 247-264. doi: 10. 1038/nrd1983.
20. Jiang, X., Tian, F., Mearow, K., Okagaki, P., Lipsky, R. H., and Marini, A. M. (2005). The excitoprotective effect of N-methyl-D-aspartate receptors is mediated by a brain-derived neurotrophic factor autocrine loop in cultured hippocampal neurons. J. Neurochem. 94, 713-722. doi: 10. 1111/j. 1471-4159. 2005. 03200. x.
21. Johansson, B., Halldner, L., Dunwiddie, T. V., Masino, S. A., Poelchen, W., Giménez-Llort, L., et al. (2001). Hyperalgesia, anxiety and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptors. Proc. Natl. Acad. Sci. U S A 98, 9407-9412. doi: 10. 1073/pnas. 161292398.
22. Johnson, J. W., and Ascher, P. (1987). Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325, 529-531. doi: 10. 1038/325529a0.
23. Köles, L., Wirkner, K., and Illes, P. (2001). Modulation of ionotropic glutamate receptor channels. Neurochem. Res. 26, 925-932. doi: 10. 1023/A: 1012380416876.
24. Kutsuwada, T., Kashiwabuchi, N., Mori, H., Sakimura, K., Kushiya, E., Araki, K., et al. (1992). Molecular diversity of the NMDA receptor channel. Nature 358, 36-41. doi: 10. 1038/358036a0.
25. Laurie, D. J., Bartke, I., Schoepfer, R., Naujoks, K., and Seeburg, P. H. (1997). Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies. Brain Res. Mol. Brain Res. 51, 23-32. doi: 10. 1016/s0169-328x(97)00206-4.
26. Lauro, C., Cipriani, R., Catalano, M., Trettel, F., Chece, G., Brusadin, V., et al. (2010). Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death. Neuropsychopharmacology 35, 1550-1559. doi: 10. 1038/npp. 2010. 26.
27. Lauro, C., Di Angelantonio, S., Cipriani, R., Sobrero, F., Antonilli, L., Brusadin, V., et al. (2008). Activity of adenosine receptors type 1 is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons. J. Immunol. 180, 7590-7596. doi: 10. 4049/jimmunol. 180. 11. 7590.
28. Lee, B., Butcher, G. Q., Hoyt, K. R., Impey, S., and Obrietan, K. (2005). Activity-dependent neuroprotection and cAMP response element-binding protein (CREB): kinase coupling, stimulus intensity and temporal regulation of CREB phosphorylation at serine 133. J. Neurosci. 25, 1137-1148. doi: 10. 1523/jneurosci. 4288-04. 2005.
29. Li, X., Zhang, Y. Y., Chen, Z. Q., Jiang, Z. L., Sun, L., Xu, L. H., et al. (2014). D-serine-induced inactivation of NMDA receptors in cultured rat hippocampal neurons expressing NR2A subunits is Ca2+-dependent. CNS Neurosci. Ther. 20, 951-960. doi: 10. 1111/cns. 12308.
30. Limatola, C., Lauro, C., Catalano, M., Ciotti, M. T., Bertollini, C., Di Angelantonio, S., et al. (2005). Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity. J. Neuroimmunol. 166, 19-28. doi: 10. 1016/j. jneuroim. 2005. 03. 023.
31. Liu, X. Q., Sheng, R., and Qin, Z. H. (2009). The neuroprotective mechanism of brain ischemic preconditioning. Acta Pharmacol. Sin. 30, 1071-1080. doi: 10. 1038/aps. 2009. 105.
32. Madry, C., Mesic, I., Betz, H., and Laube, B. (2007). The N-terminal domains of both NR1 and NR2 subunits determine allosteric Zn2+ inhibition and glycine affinity of N-methyl-D-aspartate receptors. Mol. Pharmacol. 72, 1535-1544. doi: 10. 1124/mol. 107. 040071.
33. Malenka, R. C., and Bear, M. F. (2004). LTP and LTD: an embarrassment of riches. Neuron 44, 5-21. doi: 10. 1016/j. neuron. 2004. 09. 012.
34. Martire, A., Ferrante, A., Potenza, R. L., Armida, M., Ferretti, R., Pézzola, A., et al. (2010). Remodeling of striatal NMDA receptors by chronic A(2A) receptor blockade in Huntington's disease mice. Neurobiol. Dis. 37, 99-105. doi: 10. 1016/j. nbd. 2009. 09. 012.
35. Matsui, T., Sekiguchi, M., Hashimoto, A., Tomita, U., Nishikawa, T., and Wada, K. (1995). Functional comparison of D-serine and glycine in rodents: the effect on cloned NMDA receptors and the extracellular concentration. J. Neurochem. 65, 454-458. doi: 10. 1046/j. 1471-4159. 1995. 65010454. x.
36. Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., and Seeburg, P. H. (1994). Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12, 529-540. doi: 10. 1016/0896-6273(94)90210-0.
37. Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., et al. (1992). Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256, 1217-1221. doi: 10. 1126/science. 256. 5060. 1217.
38. Navon, H., Bromberg, Y., Sperling, O., and Shani, E. (2012). Neuroprotection by NMDA preconditioning against glutamate cytotoxicity is mediated through activation of ERK 1/2, inactivation of JNK and by prevention of glutamate-induced CREB inactivation. J. Mol. Neurosci. 46, 100-108. doi: 10. 1007/s12031-011-9532-4.
39. Nicotera, P., Leist, M., and Ferrando-May, E. (1999). Apoptosis and necrosis: different execution of the same death. Biochem. Soc. Symp. 66, 69-73.
40. Papadia, S., Stevenson, P., Hardingham, N. R., Bading, H., and Hardingham, G. E. (2005). Nuclear Ca2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection. J. Neurosci. 25, 4279-4287. doi: 10. 1523/jneurosci. 5019-04. 2005.
41. Papouin, T., Ladépêche, L., Ruel, J., Sacchi, S., Labasque, M., Hanini, M., et al. (2012). Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists. Cell 150, 633-646. doi: 10. 1016/j. cell. 2012. 06. 029.
42. Pizzorusso, T., Ratto, G. M., Putignano, E., and Maffei, L. (2000). Brain-derived neurotrophic factor causes cAMP response element-binding protein phosphorylation in absence of calcium increases in slices and cultured neurons from rat visual cortex. J. Neurosci. 20, 2809-2816.
43. Rosito, M., Lauro, C., Chece, G., Porzia, A., Monaco, L., Mainiero, F., et al. (2014). Trasmembrane chemokines CX3CL1 and CXCL16 drive interplay between neurons, microglia and astrocytes to counteract pMCAO and excitotoxic neuronal death. Front. Cell. Neurosci. 8: 193. doi: 10. 3389/fncel. 2014. 00193.
44. Salvatore, C. A., Tilley, S. L., Latour, A. M., Fletcher, D. S., Koller, B. H., and Jacobson, M. A. (2000). Disruption of the A3 Adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J. Biol. Chem. 275, 4429-4434. doi: 10. 1074/jbc. 275. 6. 4429.
45. Sattler, R., and Tymianski, M. (2000). Molecular mechanisms of calcium-dependent excitotoxicity. J. Mol. Med. (Berl.) 78, 3-13. doi: 10. 1007/s001090000077.
46. Sattler, R., and Tymianski, M. (2001). Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol. Neurobiol. 24, 107-129. doi: 10. 1385/mn: 24: 1-3: 107.
47. Schmittgen, T. D., and Livak, K. J. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101-1108. doi: 10. 1038/nprot. 2008. 73.
48. Scianni, M., Antonilli, L., Chece, G., Cristalli, G., Di Castro, M. A., Limatola, C., et al. (2013). Fractalkine (CX3CL1) enhances hippocampal N-methyl-D-aspartate receptor (NMDAR) function via D-serine and adenosine receptor type A2 (A2AR) activity. J. Neuroinflammation 10: 108. doi: 10. 1186/1742-2094-10-108.
49. Shimazaki, K., Nakamura, T., Nakamura, K., Oguro, K., Masuzawa, T., Kudo, Y., et al. (1998). Reduced calcium elevation in hippocampal CA1 neurons of ischemia-tolerant gerbils. Neuroreport 9, 1875-1878. doi: 10. 1097/00001756-199806010-00038.
50. Soriano, F. X., Papadia, S., Hofmann, F., Hardingham, N. R., Bading, H., and Hardingham, G. E. (2006). Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J. Neurosci. 26, 4509-4518. doi: 10. 1523/jneurosci. 0455-06. 2006.
51. Stocca, G., and Vicini, S. (1998). Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons. J. Physiol. 507, 13-24. doi: 10. 1111/j. 1469-7793. 1998. 013bu. x.
52. Tebano, M. T., Martire, A., Rebola, N., Pepponi, R., Domenici, M. R., Grò, M. C., et al. (2005). Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of N-methyl-D-aspartate effects. J. Neurochem. 95, 1188-1200. doi: 10. 1111/j. 1471-4159. 2005. 03455. x.
53. Thomas, C. G., Miller, A. J., and Westbrook, G. L. (2006). Synaptic and extrasynaptic NMDA receptor NR2 subunits in cultured hippocampal neurons. J. Neurophysiol. 95, 1727-1734. doi: 10. 1152/jn. 00771. 2005.
54. Tovar, K. R., and Westbrook, G. L. (1999). The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J. Neurosci. 19, 4180-4188.
55. Tymianski, M., Charlton, M. P., Carlen, P. L., and Tator, C. H. (1993). Source specificity of earlly calcium neurotoxicity in cultures embryonic spinal neurons. J. Neurosci. 13, 2085-2104.
56. Volontè, C., Ciotti, M. T., and Battistini, L. (1994). Development of a method for measuring cell number: application to CNS primary neuronal cultures. Cytometry 17, 274-276. doi: 10. 1002/cyto. 990170311.
57. Wang, Y., Briz, V., Chishti, A., Bi, X., and Baudry, M. (2013). Distinct roles for μ-calpain and m-calpain in synaptic NMDAR-mediated neuroprotection and extrasynaptic NMDAR-mediated neurodegeneration. J. Neurosci. 33, 18880-18892. doi: 10. 1523/JNEUROSCI. 3293-13. 2013.
58. Yang, Z. J., Wang, B., Kwansa, H., Heitmiller, K. D., Hong, G., Carter, E. L., et al. (2013). Adenosine A2A receptor contributes to ischemic brain damage in newborn piglet. J. Cereb. Blood Flow Metab. 33, 1612-1620. doi: 10. 1038/jcbfm. 2013. 117.
59. Zhou, Q., and Sheng, M. (2013). NMDA receptors in nervous system diseases. Neuropharmacology 74, 69-75. doi: 10. 1016/j. neuropharm. 2013. 03. 030.